Podcasts about Medical research

This week, we discuss endovascular therapy for post-thrombotic syndrome, new evidence on prehospital blood transfusion strategies in trauma patients, and a trial of cefazolin for Staph. aureus bacteremia. We examine evolving approaches to thyroid cancer and share a case of a man with pancytopenia after heart transplantation. Perspectives explore psychedelic therapy, the convergence of Down syndrome and Alzheimer's disease, and treating addiction.

A daily pill can double survival time in patients with the world's deadliest cancer, according to the results of a clinical trial that experts are saying is a gamechanger and one of the biggest breakthroughs in decades. To find out more about how daraxonrasib works and how life-changing it could be for patients, Madeleine Finlay speaks to Prof Naureen Starling, consultant medical oncologist at the Royal Marsden hospital. Help support our independent journalism at theguardian.com/sciencepod

In episode two, Dr. Berwick challenges some basic assumptions: Does competition truly drive innovation in health care? He argues that cooperation often outperforms competition, citing VA-led safety advances and national patient-safety collaboratives at CMS (like the Partnership for Patients) that rewarded results and spread what worked. He also identifies some of the issues that both health care and politics face in lobbying and the undue influence of moneyed interests. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

In the first episode of this two-part 20-Minute Health Talk, Chethan Sathya, MD, sits down with Don Berwick, MD — former Center for Medicare and Medicaid Services administrator (CMS) and founder of the Institute for Healthcare Improvement (IHI). Dr. Berwick traces his path from early harrowing medical experiences to a career dedicated to improving patient care and healthcare delivery. The conversation moves to how patient solidarity could become a force for change and why simplifying to a single, public payer could create conditions that could fix the delivery of health care while actually improving patient choice and lowering costs. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

GUEST: Dr. Steven Kahn, UW Director of Diabetes Research // Can kids learn all they need in two hours of school? // SCENARIOS!

In this week's episode, Blood editor Dr. Philippe Armand interviews Drs. Manali Kamdar and Nancy L. Bartlett on their latest review article published in Blood titled “From breakthroughs to blueprints: evolving evidence and future directions in relapsed and refractory large B-cell lymphoma”. They discuss the how the advent of chimeric antigen receptor T cells, antibody-drug conjugates, and bispecific antibodies all show major increases in efficacy over legacy chemotherapy-based regimens. They also share their insights on how to transform treatment paradigms in light of these breakthroughs.

This week, we present new evidence guiding coronary intervention, a molecular mechanism of inflammatory bowel disease, and gene therapy for a recessive disease. We review antidotes for anticoagulation reversal and discuss a case of hypertension in an adolescent patient. Perspectives examine cholera control, gambling-related harms, and race-based prescribing, alongside a reflection on medicine, motherhood, and what clinicians carry with them.

Send us Fan MailThe liver is the only organ in the body that can release stored glucose to prevent low blood sugar. So why has injected insulin never been able to reach it?In this clip from our episode “Finding a Solution for GLP-1 Side Effects”, host David E. Williams and Bob Geho, Founder and CEO of Diasome, break down the biological gap at the heart of diabetes treatment and how a father's decades of research into liver-targeted insulin delivery became the founding idea behind Diasome.

Reading & Math scores went up for 3rd-8th graders - Algebra and Bio scores for High SchoolThe $77.5 million dollar project is expected to begin in September20% of us keep a flashlight in our nightstand - whats in YOURS?

I picked up the kids in my husband's car the other day. The youngest said something. The next one waited until they finished, then said something back. There was a pause. I turned around and looked at three kids not even fighting and thought, is this how pickup goes? In my car, it's on the second they get in. Someone's interrupting, someone's yelling, I'm turning the music up to drown them out, ready to throw myself onto the driveway while it's moving. Same kids. Same school. Different mum.What We CoverThe hubby-car pickup vs my-car pickup — same kids, same school, completely different rideWhat happens to your nervous system when you're already at a rolling boil before the kids even get in the carInteroception — why the signals your body's been sending all afternoon don't land in real time for an ADHD brainAlexithymia — the clinical inability to name a feeling in the moment, and the 42–51% of ADHD adults living inside itWhy mum rage feels like it came out of nowhere when it didn't, and why 'try harder, breathe more, be more like other mums at pickup' was never the answerThe dinner-time cheese moment — the fan, the dog, the kid in the shower, the TV, the iPad — and why it was never about the cheeseWho actually benefits when the rage gets called your temperament instead of your load — and why the lavender oil keeps not workingPart 1 of 2 — what's happening underneath. Part 2 is what to do about it.Related EpisodesS2 EP84: Mum Rage Part 1 (Jacinta Thomson) — https://adhdmums.com.au/podcast_episode/episode-84-i-love-my-family-but-im-so-fking-angry-mum-rage-part-1/S2 EP85: Mum Rage Part 2 — Real Tools for Real Rage — https://adhdmums.com.au/podcast_episode/episode-85-real-tools-for-real-rage-mum-rage-part-2real-tools-for-real-rage-mum-rage-part-2/EP52 HORMONES: When HRT Isn't Enough — Mum Rage & Perimenopause Explained (Dr Sunita Chelva) — https://adhdmums.com.au/podcast_episode/episode-52-hormones-when-hrt-isnt-enough-mum-rage-perimenopause-explained/EP82: Overstimulated Before 7am (Rachel Few) — https://adhdmums.com.au/adhd-podcast-episodes/rachel-few/EP12 QUICK RESET: I Can't Stop Snapping When My Child Does This — https://adhdmums.com.au/podcast_episode/episode-12-quick-reset-i-cant-stop-snapping-when-my-child-does-this-one-thing/S3: I'm Gentle With My Daughter for Ten Minutes, Then I Tell Myself to Stop Being Such a F*cking Embarrassment — https://adhdmums.com.au/adhd-podcast-episodes/im-gentle-with-my-daughter-for-ten-minutes-then-i-tell-myself-to-stop-being-such-a-fcking-embarrassment/References:Bruton, M., Hall, S. S., & Pollock, M. (2025). Diminished interoceptive accuracy in attention-deficit/hyperactivity disorder: A systematic review. Psychophysiology, 62(2), e14750. https://doi.org/10.1111/psyp.14750Edel, M.-A., Rudel, A., Hubert, C., Scheele, D., Brüne, M., Juckel, G., & Assion, H.-J. (2010). Alexithymia, emotion processing and social anxiety in adults with ADHD. European Journal of Medical Research, 15(9), 403–409. — Found 22% of ADHD adults met TAS-20 cutoff (≥61).Donfrancesco, R., Di Trani, M., Gregori, P., Auguanno, G., Melegari, M. G., Zaninotto, S., & Luby, J. (2013). Attention-deficit hyperactivity disorder and alexithymia: A pilot study. ADHD Attention Deficit and Hyperactivity Disorders, 5(4), 361–367.

Bongani Bingwa speaks to Professor Tulio de Oliveira, recipient of the Order of Mapungubwe in Gold, about promising new HIV treatments, the latest Ebola outbreak, and South Africa's growing influence in global scientific research and public health. 702 Breakfast with Bongani Bingwa is broadcast on 702, a Johannesburg-based talk radio station. Bongani makes sense of the news, interviews the key newsmakers of the day, and holds those in power to account on your behalf. The team brings you all you need to know to start your day Thank you for listening. Listen live on Primedia+ weekdays from 6 am to 9 am (SA Time) https://buff.ly/gk3y0Kj For more from the show and catch-up podcasts, visit Primedia+ here https://buff.ly/zEcM35T Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Let’s keep the conversation going online: 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.

In this Review series episode, Blood associate editor Dr. Diane Krause interviews contributing authors from the Review Series on Clonal tracking in Hematopoiesis published in volume 147 issue 23 of Blood. Dr. Alejo E. Rodriguez-Fraticelli speaks to the development of his paper, "Clonal tracing of blood stem cells across mouse and human lifespans”, which provides a detailed overview of the experimental approaches that make clonal analysis possible, and which approaches are most appropriate to use to address specific questions. Dr. Shalin H. Naik speaks about how different clonal tracking approaches have been used to address the central question of clonal fate specification of stem and progenitor cells to specific lineages in “The evolution of hematopoietic models through a clonal lens”. Finally, Dr. Federico Gaiti speaks about “Methylation-based lineage tracing in cancer”, which takes these ideas into the context of cancer, focusing on how DNA methylation can be used to reconstruct clonal relationships.  

This week, we discuss left atrial appendage closure for atrial fibrillation, oxygen strategies in respiratory failure, an all-oral treatment for acute myeloid leukemia, CAR T-cell therapy enabling kidney transplantation, and a case of a neuroepithelial tumor that developed after gene therapy. We review childhood vaccine hesitancy, follow a complex diagnostic case, and examine Perspectives on corporatization in medicine, famine and war, and the future of health care systems.

The cancellation of federally funded medical studies is affecting lives and families on the First Coast.

What happens when you know something is wrong with your body, but no one seems to be listening? In this episode, Stephanie Mitton sits down with award-winning journalist and host of TVO's Mistreated, Nam Kiwanuka, for a powerful conversation about women's health, medical dismissal, and the gaps in research that continue to impact women across Canada and beyond. Nam shares her personal experience navigating fibroids, chronic anemia, lengthy surgical wait times, and the frustration of advocating for care while trying to show up for her family and career. Together, they explore why women's health has been historically under-researched, how lived experience and evidence can work together, and what women can do to advocate for themselves in a complex health care system. This Episode Covers: Nam's personal health journey and the diagnosis that changed everything Why women are often dismissed or misdiagnosed in health care settings The impact of research gaps on conditions like fibroids, endometriosis, ADHD, migraines, and autoimmune diseases How social media can both help and hinder women searching for health information The importance of self-advocacy and knowing your medical history What femtech is and how innovation is helping address women's health challenges Practical ways women can support change in research, policy, and health care Women's health affects every aspect of our lives, from our careers and families to our confidence and wellbeing. This conversation is a reminder that your symptoms matter, your experiences matter, and your voice matters. Whether you're navigating your own health journey or supporting someone you love, you'll leave this episode with greater understanding and practical ways to advocate for better care. https://www.patreon.com/womendontdothat Instagram - http://www.instagram.com/womendontdothat/ TikTok- http://www.tiktok.com/@womendontdothat Blog- https://www.womendontdothat.com/blog Podcast- https://www.womendontdothat.com/podcast Newsletter- https://www.beaconnorthstrategies.com/contactwww.womendontdothat.com YouTube - http://www.youtube.com/@WOMENdontDOthat How to find Stephanie Mitton: Twitter/X- https://twitter.com/StephanieMitton LinkedIn - https://www.linkedin.com/in/stephaniemitton/ beaconnorthstrategies.com TikTok- https://www.tiktok.com/@stephmitton Instagram- https://www.instagram.com/stephaniemitton/ Interested in sponsorship? Contact us at hello@womendontdothat.com Produced by Duke & Castle Our Latest Blog: https://www.womendontdothat.com/post/i-don-t-do-resolutions-i-do-this-perfect-for-busy-women Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Two mothers fought British bureaucracy to obtain lifesaving cannabis medicines for their children. But most patients are having to go private – at huge cost Written and read by Kojo Koram. Help support our independent journalism at theguardian.com/longreadpod

There is a particular kind of authority that comes only from having been inside something for fifty years — from having seen it at its best, trained its practitioners, published its science, and then watched it hollow itself out from within.Dr. Peter Kowey has that authority. He holds the William Wickoff Smith Chair in Cardiovascular Research at the Lankenau Institute for Medical Research, is a professor of medicine and clinical pharmacology at Thomas Jefferson University, and spent years as chief of cardiovascular diseases at the Lankenau Heart Institute. He has published more than 450 scientific papers, trained hundreds of cardiology fellows, and served on FDA advisory panels. He has also, in the past several years, become someone who cannot stay quiet.His new book, Failure to Treat: How a Broken Healthcare System Puts Patients and Providers at Risk, is built from twenty short stories — each a fusion of real composite cases, each naming a different fracture in American medicine. Fragmented care with no coordinating physician. An electronic medical record redesigned to serve billing rather than patients. Defensive medicine that orders unnecessary tests because the malpractice system makes not ordering them dangerous. Private equity that purchases hospitals to strip and sell them. Primary care physicians asked to address four chronic conditions, review a medication list, conduct an exam, and dictate a note — in ten minutes.The book was born from a charge. Kowey's mentor was Dr. Bernard Lown: Nobel Peace Prize laureate, inventor of the defibrillator, one of the most morally serious physicians of the twentieth century. When Lown himself became a patient near the end of his long life, he encountered fragmented care, indifferent nurses, and cavalier doctors. He lived to 99, but not easily. In the years before his death, he told Kowey: "I'm really relying on you to try to do something about this."In this conversation, Kowey does not soften the diagnosis. The current administration, he says, has taken a broken system and made it exponentially worse: NIH funding running at half last year's levels, the CDC's expert panels cleared of independent scientists, vaccine skepticism in positions of authority, and cuts to Medicaid, Medicare, and veterans' healthcare that will take years to repair even if reversed tomorrow. He is blunt about what the fix requires: universal coverage, a salaried physician model, restored professional status for nurses, and loan relief tied to primary care service.He also holds out something harder to sustain than outrage: genuine hope. The people who go into medicine still go into it to help. That instinct, he believes, will outlast the systems that are trying to exploit it.The book is available on Amazon and wherever books are sold.Website:peterkoweyauthor.comIn this episode:Why fragmentation of care is the single most dangerous feature of modern American medicineHow the electronic medical record became an instrument of billing rather than careDefensive medicine, malpractice reform, and the billions they costPrivate equity in healthcare and the creation of hospital desertsThe ten-minute primary care visit and why physicians are leaving the fieldDirect-to-consumer drug advertising: the United States and New Zealand against the worldNIH, CDC, vaccines, and the public health erosion under the current administrationThe case for universal healthcare — and what getting there actually requires

In part 2, S. E. Cupp digs into how to maintain integrity in a chaotic media environment. She distinguishes healthy scientific and journalistic skepticism from conspiratorial content spirals — and explains why some “alternative voices” deserve a hearing while others don't. Cupp shares how she sets firm on‑air boundaries (including saying no to harmful pairings) to protect her family, her audience, and her mental health — and how those choices can improve the public conversation. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

Host Chethan Sathya, MD, sits down with television host and political commentator S. E. Cupp to explore how a “moderate middle” of Americans can still lead in an era obsessed with extremes. Cupp traces her journey from Republican insider to independent conservative, sharing why principles—not parties—guide her in politics and public health. They break down how nearly every hot‑button health topic gets pulled into political trenches, and what it takes to build real inroads of agreement. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

In this week's episode, Blood editor Dr. James Griffin interviews Drs. Johnny Mahlangu and Joseph Rocco on their articles published in volume 147 issue 9 of Blood.  Dr. Mahlangu discusses study details and next steps from "Efficacy and safety of marstacimab prophylaxis in hemophilia A/B with inhibitors: results from the phase 3 BASIS trial" which shows that bleeding was reduced by 93% with subcutaneous marstacimab. Dr. Rocco shares the development behind "CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis", and the insights gained from measuring a new surrogate marker of IFN-γ activity predicting severity and mortality.

The Guatemala Syphilis Study is one of the darkest chapters in medical history: a U.S., funded experiment in the 1940s where doctors deliberately infected prisoners, soldiers, psychiatric patients, and sex workers in Guatemala with syphilis and other STIs without their informed consent. Many were never properly treated, never told what had been done to them, and were used as test subjects simply because they were poor, vulnerable, and out of sight. Decades later, the study stands as a brutal reminder that “public health” and “scientific progress” have, far too often, been built on the bodies and lives of people who were never given a choice.

This week, we present new research guiding treatment of pulmonary embolism, early progress in cardiac regeneration with engineered heart tissue, and treatments for gastroesophageal cancer and Chiari malformation. We review leishmaniasis and follow a revealing neurologic case. Perspectives discuss nutrition policy, tickborne illness, structural competence in medicine, and the arrival of closure.

To mark International Clinical Trials Day this May, Cancer Trials Ireland is set to Host “Let's Talk Trials” discussing the importance of clinical trials for the advancement of medical research…Joining Ciara to discuss this is Prof. Seamus O'Reilly, Clinical Lead, Cancer Trials Ireland.

We recently got a call from a SciFri listener in Florida who has autoimmune arthritis. He told us that over the years he'd taken 10 drugs, and each out eventually stopped working. He then tried to enroll in a clinical trial for a new drug for his condition, but he was rejected specifically because he was on his 10th drug. Today we're digging into clinical trials and how they work. Are there incentives for drug developers to leave out “problem children”? Or is it more complicated than that? Flora talks with lawyer and bioethicist Holly Fernandez Lynch about what clinical trials are designed to do, how participants are chosen, and where FDA regulation comes into play. Guest: Dr. Holly Fernandez Lynch is an associate professor of medical ethics and health policy at the University of Pennsylvania. Other episodes you may enjoy: Why so many studies can't be replicatedCan ‘Suggestion-Box Science' Make Public Health More Useful? Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that's keeping you up at night? Call us: 877-4-SCIFRI Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In the first half of host Sandra Lindsay's conversation with Tareq Aro, MD, urologist, he strips away the fear and mystery surrounding kidney stones. He explains how stones form, why they're on the rise, and what's raising the risk for most people. Even better, Dr. Aro provides clear and simple advice on how to prevent the stones from causing trouble in the first place. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

In part 2, Dr. Aro explains why many stones are “silent”  — and why they suddenly announce their presence with the classic flank pain, which is among medicine's most intense. He not only clarifies what to do in the moment, but also the options available to patients, including effective new treatments. Stay tuned for his checklist of behaviors that can help, along with advice on avoiding the stones altogether. checklist to help avoid ranging from minimally invasive treatments to of recurrence if nothing changes—and an empowering checklist to lower your risk. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

 In this episode, Blood deputy editor Dr. Helen Heslop interviews contributing  authors from the Blood review series on hemophagocytic lymphohistiocytosis. Drs. Nancy Berliner and Joanne Hsu join to provide insight on their paper, “Hemophagocytic lymphohistiocytosis in adults” discussing the importance of prompt diagnosis and treatment in this high-mortality disorder, and highlight emerging agents designed to modulate disease progression. Drs. Carl Allen and Bethany Verkamp reimagine diagnostic criteria through a threshold model in “Pediatric hemophagocytic lyphohistiocytosis: current conceptualization, diagnosis, and treatment”, in order to provide individualized therapies with the goal of addressing the combined influence of genetic susceptibility and environmental triggers.

In this week's episode, Blood editor Dr. Laurie Sehn interviews Drs. Reuben Kapur and Robert Campbell on their latest articles published in Blood. This episode highlights two groundbreaking studies exploring how inflammation drives serious blood and immune-related diseases. In the first interview, Dr. Kapur discusses how inflammatory bowel disease (IBD) can both promote and worsen clonal hematopoiesis of indeterminate potential (CHIP), with large-scale human data and mouse models identifying REF1 as a key mediator and potential therapeutic target. The second segment features Dr. Campbell, who explains how heme released during malaria infection activates platelet mTOR signaling, intensifying cerebral malaria and suggesting new avenues for platelet-targeted treatments. Together, the conversations reveal how inflammatory pathways and immune signaling contribute to disease progression while opening the door to novel precision therapies. 

This week, we present a promising new therapy for dermatomyositis, evolving approaches to stroke care, the prevention of Covid-19 after household exposure, and new treatments for kidney disease. We review inflammatory myopathies and follow a complex case of multisystem illness. Perspectives discuss AI and uncertainty in clinical care, health equity, the forces shaping affordability in health care, and on unpacking the ordinary.

In the first episode of this two-part discussion, host Chethan Sathya, MD, sits down with entrepreneur Mark Cuban for a candid look at why Cuban has set his sights on fixing the economics of healthcare. Cuban shares how the “power of broke” shaped his risk mindset, why curiosity beats bravado, and how democratized knowledge and AI are lowering the barrier to entrepreneurship. He unpacks the origin and mission of his new pharmacy business, Cost Plus Drugs, which is all about radical price transparency, straightforward markups, and passing savings to patients. He also discusses his new pushes into mobile pharmaceutical manufacturing and how to apply his Cost Plus Drugs lessons to surgical procedure savings.  Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

In the second part of this conversation between 20-Minute Health Talk host Chethan Sathya, MD, and Mark Cuban, they discuss the twin forces reshaping healthcare: AI and price transparency. He argues that large language models can curb online health misinformation and even augment day-to-day clinical decisions. Cuban dives into policy, praising recent moves to rein in Medicare Advantage overpayments and explaining the drivers of branded drug costs in the U.S. He then unveils Cost Plus Wellness, a push to “open-source” direct contracts between self-insured employers and providers to reduce administrative waste and improve outcomes. Along the way, he makes the case that healthcare is surprisingly easy to disrupt when you understand costs and align incentives. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

تشهد أستراليا موسم إنفلونزا حاد، حل مبكرًا هذه السنة، بعد أن سجل العام الماضي قفزة غير مسبوقة في الإصابات. وذلك بحسب Hudson Institute of Medical Research، الذي اشار الى تسجيل أعداد كبيرة من الإصابات منذ أوائل مايو. وتحث السلطات الصحية السكان على التطعيم العاجل لمواجهة السلالة السريعة الانتشار المعروفة باسم “Super‑K”، وسط توقعات بتضاعف الحالات خلال الأسابيع المقبلة. كما يشدد الخبراء على أهمية أخذ اللقاح هذا الشهر قبل اشتداد موسم الشتاء لأن الجسم يحتاج نحو أسبوعين لبناء المناعة. هذا ويتوفر التطعيم لدى الأطباء المحليين والمراكز الصحية والصيدليات، وهو مجاني للفئات المؤهلة. كما توفر بعض الولايات لقاحات "رذاذ أنف" للأطفال لتسهيل حماية الفئات الأكثر عرضة للعدوى.

In this week's episode, Blood editor Dr. Laura Michaelis interviews Dr. Alexis Thompson, former ASH president, on her latest article published in Blood. Dr. Thompson discusses "Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemia." She explains transfusion-dependent β-thalassemia (TDT) requires rigorous, lifelong transfusion therapy and iron chelation to manage iron overload. Dr. Kwiatkowski and colleagues discuss the long-term efficacy and safety of this gene therapy in 63 patients with TDT, documenting sustained transfusion independence for up to 10 years and a safety profile consistent with that of myeloablative autologous transplantation.

On today's Good Day Health Show - ON DEMAND…Dr. Jack Stockwell, a NUCCA Chiropractor and GAPS Practitioner in SLC, UT (866.867.5070 | ForbiddenDoctor.com | JackStockwell.com), shares a holistic perspective on health news today. Dr. Jack starts with a history lesson of how the medical world of today came to be the way it is, including how medical schools came to be and how they were funded at the beginning , as well as the Rockefeller influence on how medical schools began to be funded by pharmaceutical companies, and the curriculum began to change. Back to the Rockefeller influence, the Rockefeller family fundamentally shaped modern Western medicine in the early 20th century by funding allopathic (pharmaceutical-based) medicine while sidelining holistic practices. Through massive philanthropic investments, the Rockefeller Foundation and Institute for Medical Research established standardized, laboratory-based research, creating the framework for modern "Big Pharma" and specialized medical education. Dr. Jack's job as a NUCCA Chiropractor is to remove torsion and  tension on the brain stem, where it exits the skull and turns into the spinal cord. If you're unfamiliar with what NUCCA chiropractic (National Upper Cervical Chiropractic Association) means, it is is a gentle, precise, non-invasive technique focusing on correcting the alignment between the head and neck (the atlas vertebra). It uses specialized x-rays to measure and correct spinal imbalances without any twisting, cracking, or popping, aiming to restore nervous system function and improve overall health Now, that's only half of Dr. Jack's job. The other half is to take care of his patients' overall physiology. Whether it's the nervous system, digestion, elimination, the immune system, the skeletal system, the cardiovascular system, and whatever else. Lastly, Doug joins Dr. Jack for a conversation addressing listener questions. Included is a focus on what we've learned from the Artemis astronauts, medically speaking. The Artemis astronauts provide critical data on deep-space health effects, revealing that, unlike low-Earth orbit, deep space increases risks from higher radiation and intense fluid shifts. Key findings include significant, rapid bone marrow changes, cardiovascular adaptation to microgravity (fluid shift to the head), increased vestibular disorientation upon reentry, and immune system weakening, which helps develop countermeasures for future Mars missions.All this and more in this episode of Good Day Health. Website: GoodDayHealthShow.com Social Media: @GoodDayNetworks

On this episode of Potomac Watch, Paul Gigot sits down with former Senator Ben Sasse about his diagnosis with Stage IV pancreatic cancer and his experience with experimental drug trials to battle it. They also discuss the challenges of reforming higher education, why there is so much dysfunction in the Senate, and what are the keys to a strong American comeback during its 250th anniversary. Learn more about your ad choices. Visit megaphone.fm/adchoices

This week, we present research on high-risk coronary intervention strategies, targeted therapy for pancreatic cancer, an mRNA influenza vaccine, and treatments for severe scabies and sickle cell disease. We review cerebral amyloid angiopathy and follow a complex case of a disseminated infection. Perspectives address the impact of corporate medicine on medical training and drug pricing policy.

While overall cancer rates in Canada continue to decline, reflecting decades of progress in screening and treatment, younger survivors face troubling gaps in their follow-up care. In the research article “Projected estimates of cancer in Canada in 2026” overall cancer incidence and mortality rates continue to decline when adjusted for population size, reflecting advances in screening, early detection, and treatment. But for adolescents and young adults, surviving cancer may mark the start of a more complex and less coordinated phase of care.Dr. Darren Brenner, a molecular cancer epidemiologist at the University of Calgary, reports that more than 250,000 Canadians are expected to be diagnosed with cancer in 2026, with rates per 100,000 continuing to fall. Mortality has declined for several major cancers, though increases in pancreatic and uterine cancers highlight uneven progress. Brenner notes that a growing number of survivors are now living with elevated risk of second primary cancers and will require long-term follow-up.Dr. Miranda Fidler-Benaoudia, a cancer epidemiologist at Cancer Care Alberta and co-author of the article, article “Subsequent primary neoplasm risk among survivors of cancer in adolescence and young adulthood: a population-based study from Alberta, Canada,” examines what happens after treatment for patients diagnosed between ages 15 and 39. Her study finds these survivors are twice as likely to develop a second primary cancer as their peers, often at younger ages than current screening programmes anticipate. Despite this, survivorship care is inconsistent. Patients treated in paediatric settings often receive lifelong, specialized follow-up, while those treated in adult systems may be discharged within a few years to primary care without standardized guidance or documentation. Many lack access to a family physician, and clinicians may not be equipped to manage the long-term risks associated with early cancer treatment.For clinicians, these findings raise questions about how to manage a growing population of younger cancer survivors who face elevated risks over decades. Earlier onset of second cancers and the absence of clear follow-up pathways suggest current screening frameworks and transition practices may not be sufficient for this group.Comments or questions? Text us.Join us as we explore medical solutions that address the urgent need to change healthcare. Reach out to us about this or any episode you hear. Or tell us about something you'd like to hear on the leading Canadian medical podcast.You can find Blair and Mojola on X  @BlairBigham and @DrmojolaomoleX (in English):  @CMAJ X (en français): @JAMC FacebookInstagram: @CMAJ.ca The CMAJ Podcast is produced by PodCraft Productions

Featuring Dr. Peter Kowey, Professor of Medicine at Thomas Jefferson UniversityEpisode Summary: Host JR Sparrow shares his personal journey through a recent open-heart surgery — from a routine echocardiogram that revealed a dangerously low ejection fraction (26%), to an emergency transfer to the Cleveland Clinic — and uses his experience as the backdrop for a deep conversation with renowned cardiologist and cardiac electrophysiologist Dr. Peter Kowey.Topics Covered:JR's personal health scare: echocardiogram complications, misdiagnosis, and open-heart surgeryDr. Kowey's 40+ year career in cardiac electrophysiology (heart rhythm disorders)Being the 3rd center in the world to implant a cardioverter-defibrillator (1982)Development of anti-arrhythmic drugs used worldwideMajor advancements in cardiology: ablation techniques, new blood thinners, wearable heart rhythm monitorsThe difference between clinical practice and medical researchChallenges facing the U.S. healthcare system: insurance gaps, prior authorizations, physician burnoutThe case for universal healthcare coverageThe importance of bedside manner and the "10-minute visit" problem in modern medicineAdvice for up-and-coming physicians and residentsDr. Kowey's Latest Publication: A commentary in the American Journal of Medicine on the state of the U.S. healthcare system and the difficulties patients and practitioners face in accessing quality care.Book Recommendation: Failure to Treat by Dr. Peter KoweyAvailable on AmazonWebsite: peterkoway.author.comIncludes interviews, resources, and the full message behind the bookConnect with Dr. Peter Kowey:Website: peterkoway.author.comBook: Failure to Treat on Amazon

There is a powerful shift happening - and it's centered around midlife women. Women who have spent years building careers, raising families, and showing up for everyone else are now asking a different question: What do I want? In this episode of The Retreat Leaders Podcast, Shannon Jamail sits down in person in Austin with the founders of SOL Women to talk about the rise of retreats designed specifically for midlife women - and why these experiences are more needed now than ever. SOL Women creates holistic, supportive retreat experiences that help women reconnect with themselves, prioritize their well-being, and step into a new chapter of life with clarity and confidence. Together, they explore: The unique needs of midlife women The role of retreats in holistic healing and transformation The challenges of building a retreat business from the ground up The unexpected rewards and growth that come from hosting retreats This conversation is honest, grounded, and inspiring - whether you're a retreat leader, thinking about starting a retreat business, or simply someone who believes in the power of community and connection.   What You'll Learn in This Episode • Why midlife women are seeking retreats and community more than ever • How holistic retreats support mental, emotional, and physical well-being • The real challenges of building a retreat business • The unexpected rewards of hosting retreats • How retreats create lasting connection and transformation Key Takeaways Midlife Women Are Seeking Something Deeper This stage of life often brings reflection, transition, and a desire for more alignment. Retreats provide a space for women to pause, reconnect, and redefine what's next.   Retreats Are More Than a Getaway Holistic retreats offer: community connection healing self-discovery They create experiences that go far beyond relaxation.   Building a Retreat Business Isn't Easy - But It's Worth It The founders of SOL Women share the real side of building a retreat business: the challenges the learning curve the unexpected growth And also the rewards that make it all worthwhile.   The Power of Community One of the most impactful aspects of retreats is the connection created between participants. Women leave feeling: seen supported understood And that ripple effect continues long after the retreat ends.   About SOL Women & Lauren & Nandita SOL Women creates holistic retreat experiences designed specifically for midlife women. Their retreats focus on supporting women through life transitions with a blend of wellness practices, community connection, and personal growth. Nandita Mahadevan is a multi-industry business leader, Functional Medicine enthusiast, and Certified Health & Hormone Coach with a deep passion for women's health. ​After two decades climbing the corporate ladder in the health and wellness industry, she found herself burned out—her adrenals depleted, her health suffering. This wake-up call led her on a profound journey of self-discovery, pushing her to rethink wellness beyond just the clinical approach. Her passion for women's health peaked during her own transition into perimenopause when she struggled to find the support she needed. While her background in Functional Medicine helped her understand the physical changes, the emotional and spiritual upheaval was something she had to navigate alone. ​This experience sparked the creation of Sol Women—a space dedicated to guiding women through all stages of womanhood, from hormones and health to emotional and spiritual well-being. Nandita lives in Bee Cave, Austin, with her two children, ages 13 and 8. Lauren Colletti, FNP, is a Nurse Practitioner and Board-Certified Functional Medicine expert with a deep passion for women's health. With nearly 20 years in healthcare, she has helped thousands of women navigate hormonal shifts, thyroid and digestive issues, autoimmunity, fertility, menopause, and more. ​Trained by leading experts in women's health, genomics, peptides, and longevity medicine, Lauren is dedicated to simplifying the health journey and helping women feel confident in their bodies at every stage of life—without the overwhelm. Her personalized, root-cause approach focuses on building a strong foundation while using cutting-edge therapies to create lasting wellness. She believes women deserve more than one-size-fits-all solutions—they deserve to feel heard, understood, and empowered. ​As a wife and mother to three beautiful children—Hazel, Harrison, and Holland—Lauren is continually inspired by her patients and community. She is on her own journey to thrive through every phase of life and is passionate about helping others do the same. Learn more: https://www.solwomen.com Special offer: $200 off our one day medical retreat in Austin - includes a female biomarker panel and lab review with a Functional Medicine provider ($1,200 in value).   Just mention this show!   The Retreat Leaders Podcast Resources and Links: Learn to Host Retreats Join our private Facebook Group Top 5 Marketing Tools Free Guide Get your legal docs for retreats Join Shannon in Denver at the Retreat Industry Forum  Join our LinkedIn Group Apply to be a guest on our show   Thanks for tuning into the Retreat Leaders Podcast. Remember to subscribe for more insightful episodes, and visit our website for additional resources. Let's create a vibrant retreat community together!   Subscribe:  Apple Podcast | Google Podcast | Spotify ------- TIMESTAMPS Guest Introductions (00:01:38) Lauren Coletti and Nandita introduce themselves, their backgrounds, and their focus on supporting women in midlife. The Gap in Women's Health Support (00:03:38) Discussion about the lack of holistic support for women in midlife and the importance of retreats and mindset. Personal Experiences with Perimenopause (00:04:59) Nandita shares her transition into perimenopause and the need for mindset and community support. The Power of Vulnerability and Connection (00:06:18) How vulnerability and retreats foster deep connections among high-achieving women. Origins of Soul Women on Retreat (00:06:43) Lauren and Nandita recount meeting on a Costa Rica retreat and the birth of their business idea. The Gender Gap in Medical Research (00:07:13) Discussion on how most medical research is based on men and the implications for women's health. Women's Empowerment and Cyclical Strength (00:08:23) Exploring women's hormonal cycles as a superpower and the need for empowerment. Importance of Female Connection (00:10:35) The unique need for women to connect with other women and the impact of retreats. Retreats as Safe Spaces for Vulnerability (00:13:57) How retreats create safe environments for women to open up and accelerate healing. Talking Openly About Midlife Transitions (00:14:38) The importance of discussing perimenopause, menopause, and emotional changes in community. Transformation and Joy Through Letting Go (00:16:12) Letting go of emotional burdens at retreats leads to joy and lightness. Rediscovering Playfulness in Midlife (00:16:26) Embracing a carefree, playful attitude during menopause and setting boundaries. Boundaries and Self-Protection (00:17:27) Learning to set boundaries joyfully and protect personal peace during midlife. Awareness and Support During Change (00:18:18) The need for awareness, support, and new tools as women navigate biological and mental shifts. The Mental and Emotional Side of Menopause (00:19:32) Highlighting the mental challenges of menopause and the value of open discussion. Structure of Soul Women Retreats (00:20:13) Overview of their one-day and three-day retreats, including functional medicine, mindset, and community. The Power of Less Structure (00:21:18) Realization that less programming and more connection time enhances retreat experiences. Deeper Connections in Multi-Day Retreats (00:22:33) Three-day retreats foster deeper bonds and ongoing community among participants. Lasting Impact of Retreat Friendships (00:23:18) Retreats create lifelong friendships and support networks that are hard to quantify. Vulnerability as the Root of Connection (00:24:20) Bonding through shared vulnerability, described as "joy bonding" rather than trauma bonding. Overcoming Barriers to Attending Retreats (00:25:20) Addressing women's hesitations about investing in themselves and sharing vulnerably. Intimacy and Size of Retreats (00:25:41) Smaller, curated retreats (10–15 women) foster deeper, more meaningful connections. Meeting Women Where They Are (00:26:42) Retreats accommodate all comfort levels, allowing women to open up at their own pace. The Need for In-Person Connection (00:27:03) Emphasizing the irreplaceable healing power of in-person gatherings in a digital world. Human Connection and Community (00:28:05) Comparing human need for connection to herd animals and predicting the growing importance of retreats. Upcoming Retreat Dates (00:28:29) Announcement of their next one-day and three-day retreats in Austin, Texas. Unexpected Lessons from Hosting Retreats (00:28:58) Hosts share that less structure and more connection lead to better experiences and stronger bonds. Letting Go of the Agenda (00:29:51) Learning to be present and allow organic connection rather than sticking rigidly to a schedule. Processing Time and Brain Energy (00:31:01) Participants need downtime to process, as retreats are mentally and emotionally intensive. Selling the Feeling, Not the Schedule (00:32:28) Encouragement to market retreats based on outcomes and feelings, not packed agendas. Quality Over Quantity and Pricing Insights (00:33:33) Higher-priced, smaller retreats yield better experiences and conversions than larger, cheaper ones. The Value of Transformation and Investment (00:34:34) Charging appropriately for retreats ensures energetic balance and attracts committed participants. ROI of Retreats and Lifelong Impact (00:37:06) Focusing on the return on investment for participants—transformation, longevity, and ongoing support. Lifelong Relationships and Support (00:38:10) Retreats are the catalyst for long-term partnerships and ongoing personal growth. Closing and Contact Information (00:40:13) Host thanks guests, shares where to find more information, and closes the episode.

Research astronaut and emergency physician Shawna Pandya, MD, joins host Chethan Sathya, MD, for a compelling conversation about space medicine's real-world impact. From an upcoming all‑female suborbital research mission to VR/AR training, remote imaging, and “independent medical operations” for Moon and Mars, they connect frontier challenges to better care in rural and resource-limited settings. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

In this week's episode, Blood editor Dr. James Griffin interviews Drs. Francesco Forconi and Bin Guo on their latest articles published in Blood. Dr. Guo shares insights from "Nucleoplasmic ZNF467 condensates boost hematopoietic stem cell engraftment via ICAM1-mediated mechanical reprogramming". The findings establish biomechanical regulation as an important determinant of stem cell identity and reveal new strategies for engineering stem cells with enhanced regenerative capacity. Then, Dr. Forconi discusses "DC-SIGN binding to the surface immunoglobulin oligomannose-type glycans promotes follicular lymphoma cell adhesion and survival". Persistent, low-level BCR engagement by DC-SIGN enables FL tissue retention and survival while avoiding the deleterious proapoptotic consequences of stronger, conventional antigen-driven BCR signaling. These findings help explain how FL cells exploit their microenvironmental niche.

This week, we feature advances in targeted therapy for HER2-mutant lung cancer, interventions to reduce maternal infection, an emerging treatment for hemophilia A, and a new diagnostic test for tuberculosis. We review Barrett's esophagus and follow a case of systemic illness with kidney failure. Perspectives address GLP-1 drugs and eating disorders, directed blood donation, generic drug safety, and an in-flight medical emergency.

Plus: How to increase vagal tone, improve heart health, and reduce inflammation. Kevin J. Tracey, MD, is president and CEO of the Feinstein Institutes for Medical Research at Northwell Health, a pioneer of vagus nerve research and author of the recent book, The Great Nerve: The New Science of the VagusNerve and How to Harness Its Healing Reflexes. Join Dan and Emmy Award-winning journalist Allison Gilbert at 92NY on May 17th for a live conversation about how mindfulness can deepen connection and combat loneliness, available in person and via streaming. Register here. Join Dan, Sebene Selassie, and Jeff Warren for Meditation Party, a 3-day immersive retreat at the Omega Institute in Rhinebeck, NY, October 16–18. Grab your in-person spot here, or sign up to livestream here! This episode is sponsored by: BetterHelp — Online therapy, matched to your needs. Get 10% off your first month at https://www.betterhelp.com/happier Spark — Clean energy and focus with zero sugar. Get 30% off and free shipping with code HAPPIER at https://www.drinksparkcom

Madeleine Finlay sits down with science editor Ian Sample to hear about some of the winners of the Breakthrough Prize, which held its ceremony in LA last weekend. Each prize is worth $3m and they're awarded in physics, maths and life sciences. Madeleine and Ian hear from molecular biologist Jean Bennett, who shared a life sciences prize for her work developing the world's first FDA-approved gene augmented therapy for sight loss. She explains how a chance encounter while dissecting a brain in medical school led her on a 25-year journey to develop the treatment.. Help support our independent journalism at theguardian.com/sciencepod

In part two, William Frist, MD, outlines a rural health strategy that meets people where they are, a plan that draws on community health workers, cultural literacy, and hybrid care models that blend local touch with technology. He underscores the social determinants of health, such as environment, behavior and equity. Dr. Frist also connects climate and biodiversity loss to day-to-day health, explaining how it can impact the heart, lungs and mental well-being. Keeping the discussion focused on the personal, he details actions anyone can take that have a broad-ranging impact. Finally, he explains his investment approach at Frist Cressey Ventures, which backs health services companies that close care gaps in areas such as home-based care and palliative care; these projects have the potential for strong ROI and faster impact than government-led efforts.   Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

This week, we explore new strategies for blood-pressure control after intracerebral hemorrhage, Covid-19 treatment in higher-risk patients, hormonal therapy for prostate cancer, and anesthesia for tracheal intubation. We review spinal epidural abscess and follow a case of progressive weakness and liver lesions. We examine advances in tRNA research, and Perspectives discuss the use AI in prescribing, pediatric drug research, the impact of pharmaceutical mergers, and the goals of care.

Preview for Later TodayAndrea Stricker analyzes Israel's strikes on Iranian dual-use facilities. She details how the regime co-mingles medical research with chemical weapons development, specifically highlighting a facility supplying fentanyl for the regime's mass murder.1623 PERSIA

This week, we present new research on stroke prevention, Kawasaki disease, ICU infection strategies, and immune thrombocytopenia. We review hormone therapy and thrombotic risk. A case highlights an evolving diagnosis of severe fatigue and sleep disturbance. Perspectives explore nursing workforce policy, the role of nurse scientists in rebuilding trust, and the health consequences of environmental rollbacks.

When you go to the doctor's office, your doctor has to figure out which treatment is best for you. Physicians rely on medical research and clinical trials to make sure those treatments are safe and effective. But that research has not always been inclusive, which impacts patient care. Women and people of color were only required to be included in medical trials funded by the NIH starting in 1993. Now, studies are more inclusive – but how we study sex and gender in research is still controversial. In this episode, we unpack how medicine sorts the sexes – and why it's not as simple as it seems.If you liked this episode, check out our previous one unpacking biological sex. Interested in more science behind medicine? Email us your questions at shortwave@npr.org. Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave.Listen to Short Wave on Spotify and Apple Podcasts.This episode was produced by Hannah Chinn. It was edited by our showrunner, Rebecca Ramirez. Tyler Jones checked the facts. Kwesi Lee was the audio engineer.To manage podcast ad preferences, review the links below:See pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences.NPR Privacy Policy

Unity Without Compromise with Dr. Steven LaTulippe – I expose how medical research and publication have been captured across ideological lines, silencing meaningful science and elevating flawed evidence. Drawing on personal experience, I challenge entrenched systems, defend clinical outcomes, and call for reform through open dialogue, expanded evidence standards, and new pathways that prioritize healing over institutional control...